Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Health - December, 2006
92 articles
- Congress Eyes Generic Biotech Drugs
- Democrats To Push For Medicare Changes In 2007
- Authorized Generics: An Issue To Watch In 2007
- Nurses File Class Action Wage-Fixing Suit
- Bristol-Myers To Pay $499M To Settle Pricing Charges
- Doctor Files Patent Suit Against Tyco Healthcare
- AstraZeneca's Legal Troubles Continue To Mount
- Judge Rejects Ivax Challenges To Depomed Patents
- $14M Deal Reached In Hospital Billing Case
- Health Insurer Settles Suit Over Physician Directory
- Prison Health Care Workers Agree To Contract
- "Logic Bomb" Lands Ex-Employee In Court
- Par Pharma Hit With Patent Suit Over Rythmol ANDA
- Companies Tangle Over Laser Technology
- Deaths Prompt Warnings On Rituxan
- UnitedHealth CEO Issues Company Mea Culpa
- Biovail Sues FDA Over Generic Wellbutrin
- Enzo Challenges Bioequivalence Standard
- Australian Court Bars Ranbaxy's Generic Lipitor
- Europe Strips AstraZeneca Of Key Nexium Patent
- Erectile-Dysfunction Ruling Allowed To Stand
- Ortho-McNeil Sues Barr Over Topamax Generic
- Eli Lilly Disputes New York Times Report
- Pharmacy Board Insists Generics Are Undersold
- Drug Co. Claims Licensee Breached ProQuin Deal
- Drugmakers Rail Against Compulsory Licensing
- Schering-Plough Vows To Bolster Governance
- Catheter Maker Settles Antitrust Suit For $49M
- License Agreement Turns Biotech Partners Into Rivals
- Europe To Review Validity Of Key Nexium Patent
- FDA Delays Decision On Roche Anemia Drug
- Novartis Sues To Protect Hypertension Drug
- Epix Plans To Appeal FDA Drug Decision
- FDA Lacks Timeliness In Reviewing Drug Ads: Report
- Merck: Vioxx Litigation Strategy Is Working
- Court Affirms Needle Co. Did Not Intend Infringement
- Injunction Against Pfizer's Exubera Tossed Out
- FTC Allows J&J To Buy Pfizer Unit If It Sells 4 Brands
- Court Tosses Enzo Biochem Class Action
- Jury Mulls Arguments In Latest Vioxx Trial
- No New Trial For Scrushy And Siegelman
- Savient Secures Last-Minute Generic Oxandrin Ban
- Judge OK's Sutter Health Settlement
- Accusations Fly Over Contraceptive Patch
- E.U. Approves J&J Buyout Of Pfizer Unit
- Wiggin And Dana Adds To Health Law Group
- Molina Exits Securities Suit Unscathed
- Drugstores Sue AstraZeneca Over Nexium
- NIH Scientist Pleads Guilty
- Judge Lifts Generic Oxandrin Ban
- Attorney Mistake Dooms Angiomax Patent Extension
- FTC Greenlights Barr's $2.5B Takeover Of Pliva
- McKesson Sues Over Healthcare Software Patent
- Judge Sanctions Health Net For Omitting Evidence
- Cigna Strikes Deal To End Class Action
- Cardiologists Hit HCA With Suit Over Suspensions
- Court Blocks Teva's Bid To Sell Generic Lipitor
- Skeptical Congress Approves FDA Chief
- Federal Circuit Upholds Ban On Generic Plavix
- Securities Fraud Suit Follows Pfizer's Drug Collapse
- DOJ Voices Concerns Over S.C. Health Plan
- Tenet Sidesteps Hospital Class Action
- Johnson & Johnson Faces Stent Suit
- Pfizer, Mylan Await Decision In Norvasc Patent Case
- Judge Grants Attorneys Fees In Saint Vincent Case
- Court Demands Second Look At Union Neutrality Law
- Avian Flu Infects Veterinary Medical Antitrust Suit
- Genentech, Tercica Prevail In Suit Against Insmed
- AmeriGroup Braces For Massive Damages Award
- Universal Health Reverses Lockout
- Patent Attorneys Leave Sonnenschein To Found Firm
- Fish & Richardson Reels In Another Attorney
- Doctors' Suit Against Insurers Moves Forward
- Attorney General Insists Wal-Mart, Target Have It Wrong
- Universal Health Locks Out 800 Nurses In Contract Dispute
- Alzheimer's Scientist In Hot Water Over Pfizer Work
- Savient Wins Generic Restraining Order For Oxandrin
- Medtronic Reveals $75M Settlement Over Patents
- Merck Sues Apotex Over Eye Treatments
- Federal Injunction Stays Portion Of Drug Distribution Law
- Savient Sues More Generic Cos. Over Weight-Gain Drug
- Paxil Caused Birth Defects, Lawsuit Claims
- Whistleblower Settles With Phoebe Putney Health System
- Appeals Court Affirms Dismissal Of Drug Importation Suit
- Thailand Breaks Merck's Patent For AIDS Drug
- Davis Wright Snags Health Care Veteran
- Judge Blocks McGuire's Options, Retirement Package
- Unprecedented Reporting Obligations Imposed On California Hospitals
- Brockovich Turns To Appeals Court In Latest Battle
- Magistrate Recommends Stay In Pharmaceutical Case
- NeoPharm Will Not Face SEC Charges
- Sanofi-Aventis Continues To Face Trouble Over Ketek